Fritextsökning
Innehållstyper
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Första resultaten för nygammalt läkemedel mot covid-19
I en ny studie förbättrades tillståndet för 68 procent av patienter med allvarlig covid-19 när de fick läkemedlet remdesivir. Men studien har flera svagheter oc...
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Rosling ger namn åt nytt folkhälsocenter i USA
Roslings föreläsningar och TED talks har upplyst miljontals människor om folkhälsan i världen. Nu hedras hans minne med ett nytt folkhälsocenter på University o...
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Bioreactor features disposable sensors
The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Smart "trial and error" för snabbare innovation
För att bli och förbli konkurrenskraftiga måste dagens företag och organisationer innovera i allt snabbare takt.
-
Remdesivir förkortade vårdtid vid covid-19
Det antivirala läkemedlet remdesivir var bättre än placebo i att korta vårdtiden för svårt covid-19-sjuka, enligt studiedata som nu publicerats.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
De är Sveriges högst rankade forskare
På en lista med över 6 600 framstående forskare finns nära 50 forskare från svenska institutioner med.
-
Omega-3 utreds
Nyligen publicerade studier antyder att omega-3-fettsyror inte skyddar mot hjärt-kärlsjuksjukdom hos personer som tidigare haft en hjärtinfarkt.
-
Fondmedel till forskning
Insamlingsstiftelsen Cancer-och Allergifonden ger medel till 23 forskningsprojekt.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
BREAKING